 |
| CrossRef Text and Data Mining |
| Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining. |
| Achievement of LDL-C Targets Defined by ESC/EAS (2011) Guidelines in Risk-Stratified Korean Patients with Dyslipidemia Receiving Lipid-Modifying Treatments |
| Ye Seul Yang, Seo Young Lee, Jung-Sun Kim, Kyung Mook Choi, Kang Wook Lee, Sang-Chol Lee, Jung Rae Cho, Seung-Jin Oh, Ji-Hyun Kim, Sung Hee Choi |
|
Endocrinol Metab. 2020;35(2):367-376. Published online June 24, 2020 DOI: https://doi.org/10.3803/EnM.2020.35.2.367 |
|
Achievement of LDL-C Targets Defined by ESC/EAS (2011) Guidelines in Risk-Stratified Korean Patients with Dyslipidemia Receiving Lipid-Modifying Treatments Endocrinology and Metabolism. 2020;35(2):367-376  Lipid target achievement among patients according to ESC/EAS and ACC/AHA guidelines in a lipid clinic Atherosclerosis. 2014;235(2):e289 News from the literature: Focus on joint ESC/EAS dyslipidemia guidelines Atherosclerosis. 2012;220(1):42-44 Current lipid lowering treatment and attainment of LDL targets recommended by ESC/EAS guidelines in very high-risk patients with established atherosclerotic cardiovascular disease: Insights from the START registry International Journal of Cardiology. 2020;316:229-235 2015 Korean Guidelines for Management of Dyslipidemia Journal of Lipid and Atherosclerosis. 2015;4(1):61 2019 ESC/EAS Guidelines for themanagement of dyslipidaemias: lipid modification to reduce cardiovascular risk Revista Española de Cardiología (English Edition). 2020;73(5):403 Corrigendum to: 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk European Heart Journal. 2019;41(44):4255-4255 What is the potential cardiovascular risk reduction associated with achieving LDL-C levels recommended in the ESC/EAS guidelines for very high-risk patients? Data from 18 European countries European Heart Journal. 2020;41(Supplement_2): Critical Appraisal of the Clinical Practice Guidelines for the Management of Dyslipidaemias: Lipid Modification to Reduce Cardiovascular Risk: European Society of Cardiology (ESC) and European Atherosclerosis Society (ESC/EAS) 2019 Guidelines Journal of Pharmaceutical Health Services Research. 2020;11(4):423-427 Control of cardiovascular risk factors according to score system in hypertensive patients: ESC/EAS 2016 and 2019 dyslipidemia guidelines comparison Atherosclerosis. 2020;315:e178 |
